Circadian molecular clocks and cancer
- PMID: 24099911
- DOI: 10.1016/j.canlet.2013.09.040
Circadian molecular clocks and cancer
Abstract
Physiological processes such as the sleep-wake cycle, metabolism and hormone secretion are controlled by a circadian rhythm adapted to 24h day-night periodicity. This circadian synchronisation is in part controlled by ambient light decreasing melatonin secretion by the pineal gland and co-ordinated by the suprachiasmatic nucleus of the hypothalamus. Peripheral cell autonomous circadian clocks controlled by the suprachiasmatic nucleus, the master regulator, exist within every cell of the body and are comprised of at least twelve genes. These include the basic helix-loop-helix/PAS domain containing transcription factors; Clock, BMal1 and Npas2 which activate transcription of the periodic genes (Per1 and Per2) and cryptochrome genes (Cry1 and Cry2). Points of coupling exist between the cellular clock and the cell cycle. Cell cycle genes which are affected by the molecular circadian clock include c-Myc, Wee1, cyclin D and p21. Therefore the rhythm of the circadian clock and cancer are interlinked. Molecular examples exist including activation of Per2 leads to c-myc overexpression and an increased tumor incidence. Mice with mutations in Cryptochrome 1 and 2 are arrhythmic (lack a circadian rhythm) and arrhythmic mice have a faster rate of growth of implanted tumors. Epidemiological finding of relevance include 'The Nurses' Health Study' where it was established that women working rotational night shifts have an increased incidence of breast cancer. Compounds that affect circadian rhythm exist with attendant future therapeutic possibilities. These include casein kinase I inhibitors and a candidate small molecule KL001 that affects the degradation of cryptochrome. Theoretically the cell cycle and malignant disease may be targeted vicariously by selective alteration of the cellular molecular clock.
Keywords: Breast cancer; Casein kinase I; Circadian clocks; Shift-work; Supra-chiasmatic nucleus.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Temporal expression of seven clock genes in the suprachiasmatic nucleus and the pars tuberalis of the sheep: evidence for an internal coincidence timer.Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13890-5. doi: 10.1073/pnas.212517599. Epub 2002 Oct 8. Proc Natl Acad Sci U S A. 2002. PMID: 12374857 Free PMC article.
-
Circadian profile and photic regulation of clock genes in the suprachiasmatic nucleus of a diurnal mammal Arvicanthis ansorgei.Neuroscience. 2003;116(2):583-91. doi: 10.1016/s0306-4522(02)00654-1. Neuroscience. 2003. PMID: 12559113
-
Daily expression of clock genes in central and peripheral tissues of tree sparrow (Passer montanus).Chronobiol Int. 2019 Jan;36(1):110-121. doi: 10.1080/07420528.2018.1523185. Epub 2018 Oct 26. Chronobiol Int. 2019. PMID: 30365349
-
Melatonin feedback on clock genes: a theory involving the proteasome.J Pineal Res. 2015 Jan;58(1):1-11. doi: 10.1111/jpi.12189. Epub 2014 Nov 22. J Pineal Res. 2015. PMID: 25369242 Review.
-
[Molecular mechanisms of circadian clock functioning].Ukr Biokhim Zh (1999). 2011 May-Jun;83(3):5-24. Ukr Biokhim Zh (1999). 2011. PMID: 21888051 Review. Ukrainian.
Cited by
-
Construction of recombinant pEGFP-N1-hPer2 plasmid and its expression in osteosarcoma cells.Oncol Lett. 2016 Apr;11(4):2768-2772. doi: 10.3892/ol.2016.4291. Epub 2016 Mar 1. Oncol Lett. 2016. PMID: 27073550 Free PMC article.
-
Chronotype and postmenopausal breast cancer risk among women in the California Teachers Study.Chronobiol Int. 2019 Nov;36(11):1504-1514. doi: 10.1080/07420528.2019.1658113. Epub 2019 Aug 27. Chronobiol Int. 2019. PMID: 31452403 Free PMC article.
-
Sleep problems and risk of cancer incidence and mortality in an older cohort: The Cardiovascular Health Study (CHS).Cancer Epidemiol. 2022 Feb;76:102057. doi: 10.1016/j.canep.2021.102057. Epub 2021 Nov 17. Cancer Epidemiol. 2022. PMID: 34798387 Free PMC article.
-
The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis.Front Oncol. 2014 May 19;4:96. doi: 10.3389/fonc.2014.00096. eCollection 2014. Front Oncol. 2014. PMID: 24904820 Free PMC article. Review.
-
Identification and characterization of the CDK1-BMAL1-UHRF1 pathway driving tumor progression.iScience. 2023 Mar 31;26(4):106544. doi: 10.1016/j.isci.2023.106544. eCollection 2023 Apr 21. iScience. 2023. PMID: 37123229 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases